Less than six months after it was founded, China-based iCarbonX has completed a round featuring Tencent and Vcanbio that values it at $1bn.
China-based healthcare analytics company iCarbonX raised RMB1bn ($154m) in a series A round yesterday led by internet company Tencent, Netease Tech reported yesterday.
The round also included biotechnology producer Vcanbio Cell & Gene Engineering Corporation. A report in January this year suggested the round would be sized at $106m and would value iCarbonX at $760m.
Founded in October 2015, iCarbonX is working on a big data analytics platform that collects medical data and combines it with data from smart…
